Nuage Therapeutics

Description

Nuage Therapeutics targets intrinsically disordered proteins to develop precision cancer therapies by exploiting their tendency to form transient higher-order assemblies and directly targeting oncogenic transcription factors.

Nuage Therapeutics is located in the Barcelona ecosystem.

Related

• MogrifyMogrify develops platform technologies for direct cellular reprogramming that analyze transcriptomic, gene regulatory, and epigenetic data…
• Betaglue® TherapeuticsBetaglue® Therapeutics develops localized radiotherapeutic platforms delivering radiation directly into solid tumors, producing precision…
• ALLOXALLOX uses high-throughput experiments with genetics and AI to learn biophysical parameters of protein function, supporting systematic…
• Integra TherapeuticsIntegra Therapeutics engineers FiCAT and related gene-writing tools that combine CRISPR-Cas precision with engineered transposase transfer…
• Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
• Ability PharmaAbility Pharma develops oral targeted anticancer compounds that induce cytotoxic autophagy in cancer cells and advances clinical-stage…
• SpliceBioSpliceBio builds protein splicing–based genetic medicines and develops therapeutics for diseases caused by mutations in large genes,…
• ORF GeneticsORF Genetics produces animal-free, plant-made recombinant growth factors and cytokines used to support human cell cultures, skincare…
• NexstimNexstim develops a navigated transcranial magnetic stimulation system that uses sophisticated 3D navigation to provide accurate,…